[ad_1]
The “Sanofi” announcement came shortly after a statement by Secretary of State for the Economy, Anis Pagnier Ronacher, on “Radio Sud,” in which prioritizing the United States would be “unacceptable.”
She said: “For us, it would be unacceptable for this or that country to weigh in to obtain it on a financial pretext.”
Sanofi CEO Paul Hudson said Wednesday that his company would provide the United States “first” with the vaccine when it is reached, because this country has invested financially to support research by the giant company.
In an interview with Bloomberg News, he explained that the United States government “has the right to obtain significant pre-orders” because the United States “has invested in trying to protect its population.”
But Pogelo explained, “The goal is to make the vaccine available in the United States, France and the European Union in the same way,” adding that this would be possible “if Europeans act at the same speed as Americans.”
“>
The French director of the pharmaceutical giant, Sanofi, confirmed that he will not give priority to the United States when distributing the vaccine if the European Union proves to be equally effective in financing its manufacture.
“Americans are effective in this period. The European Union must be equally effective in helping us secure this vaccine very quickly,” French director Sanofi Olivier Bugelo told BFMTV.
The “Sanofi” announcement came shortly after a statement by Secretary of State for the Economy, Anis Pagnier Ronacher, on “Radio Sud,” in which prioritizing the United States would be “unacceptable.”
She said: “For us, it would be unacceptable for this or that country to weigh in to obtain it on a financial pretext.”
Sanofi CEO Paul Hudson said Wednesday that his company would provide the United States “first” with the vaccine when it is reached, because this country has invested financially to support research by the giant company.
In an interview with Bloomberg News, he explained that the United States government “has the right to obtain significant pre-orders” because the United States “has invested in trying to protect its population.”
But Pogelo explained, “The goal is to make the vaccine available in the United States, France and the European Union in the same way,” adding that this would be possible “if Europeans act at the same speed as Americans.”
